BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 34091065)

  • 1. Thromboprophylaxis strategies to improve the prognosis of COVID-19.
    Bertoletti L; Bikdeli B; Zuily S; Blondon M; Mismetti P
    Vascul Pharmacol; 2021 Aug; 139():106883. PubMed ID: 34091065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 coagulopathy and thrombosis: Analysis of hospital protocols in response to the rapidly evolving pandemic.
    Parks AL; Auerbach AD; Schnipper JL; Anstey JE; Sterken DG; Hecht TEH; Fang MC;
    Thromb Res; 2020 Dec; 196():355-358. PubMed ID: 32977136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Venous Thromboembolism in Patients Discharged after COVID-19 Hospitalization.
    Engelen MM; Vandenbriele C; Balthazar T; Claeys E; Gunst J; Guler I; Jacquemin M; Janssens S; Lorent N; Liesenborghs L; Peerlinck K; Pieters G; Rex S; Sinonquel P; Van der Linden L; Van Laer C; Vos R; Wauters J; Wilmer A; Verhamme P; Vanassche T
    Semin Thromb Hemost; 2021 Jun; 47(4):362-371. PubMed ID: 33893631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticoagulant interventions in hospitalized patients with COVID-19: A scoping review of randomized controlled trials and call for international collaboration.
    Tritschler T; Mathieu ME; Skeith L; Rodger M; Middeldorp S; Brighton T; Sandset PM; Kahn SR; Angus DC; Blondon M; Bonten MJ; Cattaneo M; Cushman M; Derde LPG; DeSancho MT; Diehl JL; Goligher E; Jilma B; Jüni P; Lawler PR; Marietta M; Marshall JC; McArthur C; Miranda CH; Mirault T; Morici N; Perepu U; Schörgenhofer C; Sholzberg M; Spyropoulos AC; Webb SA; Zarychanski R; Zuily S; Le Gal G;
    J Thromb Haemost; 2020 Nov; 18(11):2958-2967. PubMed ID: 32888372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Venous thromboembolism in COVID-19: systematic review of reported risks and current guidelines.
    Fontana P; Casini A; Robert-Ebadi H; Glauser F; Righini M; Blondon M
    Swiss Med Wkly; 2020 Jun; 150():w20301. PubMed ID: 32640479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of Venous Thromboembolism in Acutely Ill Medical Patients: A New Era.
    MacDougall K; Spyropoulos AC
    Semin Respir Crit Care Med; 2021 Apr; 42(2):308-315. PubMed ID: 33548931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New paradigms in venous thromboprophylaxis of medically ill patients.
    Spyropoulos AC; Raskob GE
    Thromb Haemost; 2017 Aug; 117(9):1662-1670. PubMed ID: 28640324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Empirical systemic anticoagulation is associated with decreased venous thromboembolism in critically ill influenza A H1N1 acute respiratory distress syndrome patients.
    Obi AT; Tignanelli CJ; Jacobs BN; Arya S; Park PK; Wakefield TW; Henke PK; Napolitano LM
    J Vasc Surg Venous Lymphat Disord; 2019 May; 7(3):317-324. PubMed ID: 30477976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of evidence to support thromboprophylaxis in hospitalized medical patients with cancer.
    Carrier M; Khorana AA; Moretto P; Le Gal G; Karp R; Zwicker JI
    Am J Med; 2014 Jan; 127(1):82-6.e1. PubMed ID: 24384102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombotic risk in patients with COVID-19.
    Pancaldi E; Pascariello G; Cimino G; Cersosimo A; Amore L; Alghisi F; Bernardi N; Calvi E; Lombardi CM; Vizzardi E; Metra M
    Rev Cardiovasc Med; 2021 Jun; 22(2):277-286. PubMed ID: 34258896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular Disease Patient Information Page: Cancer-associated thrombosis.
    Evans NS; Khorana AA
    Vasc Med; 2020 Jun; 25(3):286-288. PubMed ID: 32384252
    [No Abstract]   [Full Text] [Related]  

  • 12. Extended-Duration Thromboprophylaxis Among Acute Medically Ill Patients: An Unmet Need.
    Korjian S; Daaboul Y; Halaby R; Goldhaber SZ; Cohen AT; Singh K; Susheela AT; Harrington RA; Hull RD; Hernandez AF; Gibson CM
    J Cardiovasc Pharmacol Ther; 2016 May; 21(3):227-32. PubMed ID: 26341120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improve the results of phase II trials of thromboprophylaxis with the new oral anticoagulant drugs.
    Zufferey PJ; Samama CM; Rosencher N
    Thromb Haemost; 2010 Dec; 104(6):1083-4. PubMed ID: 20886198
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy and safety of extended thromboprophylaxis for medically ill patients. A meta-analysis of randomised controlled trials.
    Dentali F; Mumoli N; Prisco D; Fontanella A; Di Minno MN
    Thromb Haemost; 2017 Feb; 117(3):606-617. PubMed ID: 28078350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thromboprophylaxis after knee arthroscopy and lower leg casting.
    Vasa; 2017 Jul; 46(4):319-320. PubMed ID: 28679356
    [No Abstract]   [Full Text] [Related]  

  • 16. Systematic assessment of venous thromboembolism in COVID-19 patients receiving thromboprophylaxis: incidence and role of D-dimer as predictive factors.
    Artifoni M; Danic G; Gautier G; Gicquel P; Boutoille D; Raffi F; Néel A; Lecomte R
    J Thromb Thrombolysis; 2020 Jul; 50(1):211-216. PubMed ID: 32451823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of symptomatic venous thromboembolism following hospitalization for coronavirus disease 2019: Prospective results from a multi-center study.
    Rashidi F; Barco S; Kamangar F; Heresi GA; Emadi A; Kaymaz C; Jansa P; Reis A; Rashidi A; Taghizadieh A; Rezaeifar P; Moghimi M; Ghodrati S; Mozafari A; Foumani AA; Tahamtan O; Rafiee E; Abbaspour Z; Khodadadi K; Alamdari G; Boodaghi Y; Rezaei M; Muhammadi MJ; Abbasi M; Movaseghi F; Koohi A; Shakourzad L; Ebrahimi F; Radvar S; Amoozadeh M; Fereidooni F; Naseari H; Movalled K; Ghorbani O; Ansarin K
    Thromb Res; 2021 Feb; 198():135-138. PubMed ID: 33338976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. D-Dimer, Fibrinogen, and IL-6 in COVID-19 Patients with Suspected Venous Thromboembolism: A Narrative Review.
    Eljilany I; Elzouki AN
    Vasc Health Risk Manag; 2020; 16():455-462. PubMed ID: 33223833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Consensus-based clinical recommendations and research priorities for anticoagulant thromboprophylaxis in children hospitalized for COVID-19-related illness.
    Goldenberg NA; Sochet A; Albisetti M; Biss T; Bonduel M; Jaffray J; MacLaren G; Monagle P; O'Brien S; Raffini L; Revel-Vilk S; Sirachainan N; Williams S; Zia A; Male C;
    J Thromb Haemost; 2020 Nov; 18(11):3099-3105. PubMed ID: 33174388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of Venous Thromboembolism and Benefits and Risks of Thromboprophylaxis After Cardiac Surgery: A Systematic Review and Meta-Analysis.
    Ho KM; Bham E; Pavey W
    J Am Heart Assoc; 2015 Oct; 4(10):e002652. PubMed ID: 26504150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.